Review of Novel Pomegranate-Nanoparticles Ameliorate Cisplatin-Induced Nephrotoxicity and Improves Cisplatin Anti-Cancer Efficacy in Ehrlich Carcinoma Mice Model

Pre-publication Review of

Novel Pomegranate-Nanoparticles Ameliorate Cisplatin-Induced Nephrotoxicity and Improves Cisplatin Anti-Cancer Efficacy in Ehrlich Carcinoma Mice Model

Reviewed On January 13, 2022 , February 01, 2022 , and February 07, 2022

Verified

Submitted to

Reviewed by

Actions

Reviewed on January 13, 2022

Source

Reviewed on February 01, 2022

Source

Reviewed on February 07, 2022

Source

References

Steve, H., S., A. M., O., A. I., H., S. S., K., A. J. S., Torki, A., Yousef, A., Shaker, A. S., J., B. D., Shaker, M. 2022. Novel Pomegranate-Nanoparticles Ameliorate Cisplatin-Induced Nephrotoxicity and Improves Cisplatin Anti-Cancer Efficacy in Ehrlich Carcinoma Mice Model. Molecules.